跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EZECREST COMPOSITE PACK 10 mg+20 mg ezetimibe10 mg tablet and rosuvastatin (as calcium) 20 mg tablet blister composite pack - TGA Drug Approval Details
Approvals
/
TGA
/
EZECREST COMPOSITE PACK 10 mg+20 mg ezetimibe10 mg tablet and rosuvastatin (as calcium) 20 mg tablet blister composite pack
Approved
STANDARD
EZECREST COMPOSITE PACK 10 mg+20 mg ezetimibe10 mg tablet and rosuvastatin (as calcium) 20 mg tablet blister composite pack
Pharmacor Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
31ec19709eed9a43
Company
Pharmacor Pty Ltd
Type
Standard
Approval Details
Approval Id
31ec19709eed9a43
Product Name
EZECREST COMPOSITE PACK 10 mg+20 mg ezetimibe10 mg tablet and rosuvastatin (as calcium) 20 mg tablet blister composite pack
Artg Id
375655
Artg Name
EZECREST COMPOSITE PACK 10 mg+20 mg ezetimibe10 mg tablet and rosuvastatin (as calcium) 20 mg tablet blister composite pack
Sponsor
Pharmacor Pty Ltd
Company Detail Path
/organization/pharmacor-sa-pty-ltd
Artg Date
2023-02-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-01227-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-PI-01228-1
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
31ec19709eed9a43
Type
Standard
Back to TGA Approvals